[MO40] Mini-Oral Session 40　Lung Cancer / Thoracic Cancer 6（Biomarker）
【E】

[MO40-4] Differential immune-related microenvironment determines PD-1/PD-L1 blockade efficacy in patients with advanced NSCLC

^○Masayuki Shirasawa^1,2, Tatsuya Yoshida^1,3, Yukiko Shimoda¹, Daisuke Takayanagi², Kouya Shiraishi², Takashi Kubo⁴, Sachiyo Mitani⁴, Yuji Matsumoto¹, Ken Masuda¹, Yuki Shinno¹, Yusuke Okuma¹, Yasushi Goto¹, Hidehito Horinouchi¹, Hitoshi Ichikawa⁴, Takashi Kohno², Noboru Yamamoto^1,3, Shun-Ichi Watanabe⁵, Noriko Motoi⁶, Yuichiro Ohe¹ (1.Department of Thoracic Oncology, National Cancer Center Hospital, 2.Division of Genome Biology, National Cancer Center Research Institute, 3.Department of Experimental Therapeutics, National Cancer Center Hospital, 4.Department of Clinical Genomics, National Cancer Center Research Institute, 5.Department of Thoracic Surgery, National Cancer Center Hospital, 6.Department of Diagnostic Pathology, National Cancer Center Hospital)